Updates are available Correction dated 2021-03-19
Click to view Correction: https://0-doi-org.brum.beds.ac.uk/10.1186/s12936-021-03651-z
-
Authors
Anyorigiya, Thomas A.
Castel, Sandra
Mauff, Katya
Atuguba, Frank
Ogutu, Bernhards
Oduro, Abraham
Dosoo, David
Asante, Kwaku-Poku
Owusu-Agyei, Seth
Dodoo, Alexander
Hodgson, Abraham
Binka, Fred
Workman, Lesley J.
Allen, Elizabeth N.
Denti, Paolo
Wiesner, Lubbe
Barnes, Karen I. http://orcid.org/0000-0002-0107-3063
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (48363.01)
National Foundation
- License Information
-
More Information
Article History
Received: 3 July 2020
Accepted: 15 December 2020
First Online: 6 January 2021
Change Date: 19 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://0-doi-org.brum.beds.ac.uk/10.1186/s12936-021-03651-z
Ethics approval and consent to participate
: The parent study was approved by the Ghana Health Service Ethical Review committee, the Navrongo Health Research Centre Institutional Review board (NHRCIRB) and Kintampo Health Research Centre Ethical Review Committee. The pharmacokinetic sub-study was approved by the University of Cape Town Faculty of Health Sciences Human Research Ethics Committee and the NHRCIRB. The study was conducted according to the ethical principles of the Declaration of Helsinki [CitationRef removed], Good Clinical Practice [CitationRef removed] and local ethical and regulatory requirements. Written informed consent was obtained from all patients aged 18 years or older prior to the performance of study related procedures, such as collection of blood samples for drug concentration measurements, filter paper for genotyping and urine samples for pregnancy tests. Informed consent was obtained from the parents or guardians of patients aged less than 18 years. In addition, assent was obtained from patients 12–17 years.
: Not applicable.
: The authors declare that they have no competing interests.
